| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Verona Pharma secures $30m debt facility from Silicon Valley Bank
StockMarketWire.com
|
Respiratory diseases focused Verona Pharma said it had entered into a debt financing facility for up to $30 million with Silicon Valley Bank.
The capital provided further financial flexibility to support pre-commercialization activities for ensifentrine, a product candidate currently in Phase 3 trials.
Story provided by StockMarketWire.com
|
|
|
|
|
|
